Plumbline Life Sciences, Inc.

XKON:A222670 Stock Report

Market Cap: ₩11.5b

Plumbline Life Sciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Anthony K. Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership24.7%
Management average tenureno data
Board average tenure4.5yrs

Recent management updates

Recent updates

CEO

Anthony K. Kim

no data

Tenure

Mr. Anthony K. Kim serves as the Chief Executive Officer and President of Plumbline Life Sciences, Inc. and serves as its Director. Mr. Kim served as a Director of Investor Relations at VGX Pharmaceuticals...

Board Members

NamePositionTenureCompensationOwnership
Anthony K. Kim
Presidentno datano data24.71%
₩ 2.8b
Eun Jin Kim
Director & CSDO3.1yrsno datano data
David B. Weiner
Chief of Veterinary Advisory Boardno datano datano data
Yong-Ho Park
Member of Veterinary Advisory Boardno datano datano data
Joo Hyun Kim
Independent Directorno datano datano data
Sang Joon Lee
Independent Outside Director5.1yrsno datano data
Sung Dae Jung
Member of Veterinary Advisory Boardno datano datano data
Jae Bong Moon
Member of Veterinary Advisory Boardno datano datano data
Yong Pal Kim
Member of Veterinary Advisory Board5.1yrsno datano data
Jungul Choi
Auditor & Director3.8yrsno datano data

4.5yrs

Average Tenure

Experienced Board: A222670's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:17
End of Day Share Price 2025/02/07 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Plumbline Life Sciences, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.